Bought AIS, in at 1.87.

Antares Pharma, (AIS) develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products.

Tags: , ,






Thanks for reading

Want to know when I post again? Subscribe to the StockRake feed: .